Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A Dose‐Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis

Clinical Pharmacology & Therapeutics(2023)10.1002/cpt.3108Source: DataRank Database

A Dose‐Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis is a research paper published in Clinical Pharmacology & Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.87)OA: hybridTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

John D. Szumowski ORCID,Nabila Akbar,Prema Shanmugasundaram,Anilkumar Jain,Marasamy Bathragiri

Live enrichment

PubMed:37983978 PMC:PMC7615557 OpenAlex:https://openalex.org/W4388852212

NIAID NIH HHS

Grant: R01 AI054503

Wellcome Trust

Grant: 223103

NIAID NIH HHS

Grant: T32 AI007044

National Institutes of Health

Grant: 5T32AI007044-17

HOST DEFENSE IN ALLERGY AND INFECTIOUS DISEASES

Wellcome Trust

Grant: unidentified

unidentified

FWCI

1.87

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3108

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.3108

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.3108

journalhttps://doi.org/10.1002/cpt.3108

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37983978

Fields of Study

Tuberculosis Research and EpidemiologyAntibiotics Pharmacokinetics and EfficacyPneumocystis jirovecii pneumonia detection and treatment0303 health sciences03 medical and health sciencesHumansAntitubercular AgentsMycobacterium tuberculosisRifampinTuberculosisVerapamil

MeSH Terms

Antitubercular AgentsHumansMycobacterium tuberculosisRifampinTuberculosisVerapamil

Keywords

VerapamilPharmacologyMedicineEffluxTuberculosisInternal medicineChemistryCalciumBiochemistryPathologyClinical ResearchAntitubercular AgentsHumansMycobacterium tuberculosisRifampinArticle

Sustainable Development Goals

SDG 0: Good health and well-being